Abstract
Twenty-four patients with Down syndrome and leukemia were studied. A strong male predominace (79%) was found. Age ranged between 18 months and 15 years (mean: 5 6/12); 54% of the patients were less than 4 years of age at the time of diagnosis. A preleukemic phase was noted in 6/24 patients. This phase, characterized essentially by thrombocytopenia, lasted from 2–8 months. Patients with preleukemia had unusual blast cell morphology and involvement of more than one cell line (dyserythropoiesis, hypolobulated megakaryocytes) and were probably M7 leukemias. All patients demon-strated severe methotrexate toxicity at standard methotrexate doses. Toxicity, manifesting as mouth ulcerations and bone marrow depression was seen regardless of the route of administration (oral, intrathecal or intravenous). A 30%–50% reduction of the standard dose was tolerated. Methotrexate absorption and clearance were studied in two patients and were found to be normal. We postulate that the observed toxicity of methotrexate may be due to a gene dosage effect for enzymes known to be on chromosome 21 and intervening in purine metabolism. Increased purine synthesis implies greater tetrahydrofolic acid demands and therefore greater sensitivity to an antifolate agent.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- All:
-
acute lymphoblastic leukemia
- AML:
-
acute myelogenous leukemia
- MTX:
-
methotrexate
- 6-MP:
-
6-mercaptopurine
- ITP:
-
idiopathic thrombocytopenic purpura
- IV:
-
intravenous
- po:
-
oral administration
References
Bain BJ, Catovsky D, O'Brien M, Prentice HG, Lawlor E, Kumaran TO, McCann SR, Matutes E, Galton DAG (1981) Megakaryo blastic leukemia presenting as acute myelofibrosis. A study of four cases with the platelet peroxidase reaction. Blood 58:206–213
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukemias. French-American-British (FAB) cooperative group. Br J Haematol 33:451–458
Bevan D, Rose M, Greaves M (1982) Leukemia of the platelet precursors: diverse features of four cases. Br J Haematol 51:147–164
Brewster HF, Cannon HE (1930) Acute lymphatic leukemia: report of case in an eleven month mongolian idiot. New Orleans Med Surg J 82:872–876
Chan WC, Byrnes RK, Kim TH, Verras A, Schick C, Green RS, Ragab AH (1983) Acute megakaryoblastic leukemia in early childhood. Blood 62:92–98
Chu JT, Weldon BC (1982) Acute leukemia in a patient with Down's syndrome and transient congenital leukemia (Letter). Am J Dis Child 136:367
Debiec-Rych M, Kaluzewsk B, Zajackow D, Pokuszysk K (1982) Mosaicism 48XX,+8,+21/47XX,+21 in Down's syndrome and rapid progression from preleukemia to acute leukemia (Letter). Lancet 2:448–449
Evans DIK (1975) Acute myelofibrosis in children with Down's syndrome. Arch Dis Child 50:458–462
Frankel LS, Pullen J, Boyett J, Eastment C, Ragab A, Hvizdala E, Berry D, Sexauer C, Crist W, Vietti T (1986) Excessive drug toxicity in children with Down's syndrome treated for acute lymphocytic leukemia (ALL) despite similarity of clinical and biological features to other patients. Proceedings of ASCO, p 161 (abstr 631)
Golomb HM, Rowley JD (1981) Significance of cytogenetic abnormalities in acute leukemia. Hum Pathol 12:515–522
Heaton DC, Fitzgerald PH, Fraser J, Abbott GD (1981) Transient leukemoid proliferation of the cytogenically unbalanced +21 line of a constitutional mosaic boy. Blood 57:883–887
Honda F, Punnett HH, Charney E, Miller G, Thiede HA (1964) Serial cytogenic and hematologic studies on a mongol with trisomy 21 and acute congenital leukemia. J Pediatr 65:880–887
Kalwinsky D, Pui CH, Bowman WP (1982) Acute lymphocytic leukemia (ALL) in children with Down's syndrome. Proceedings of ASCO, p 126 (abstr C-488)
Kamen BA, Nylen PA, Camitta BM, Bertino JR (1981) Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. Br J Haematol 49:355–360
Lazarus KH, Heerema NA, Palmer CG, Baehner RL (1981) The myeloproliferative reaction in a child with Down's syndrome: cytological and chromosomal evidence for a transient leukemia. Am J Hematol 2:417–423
Lejeune J (1979) Investigations biochimiques et trisomies 21. Ann Génét 22:67–75
Lejeune J, Réthoré MO, deBlois MC, Mannoury-Burolla C, Mir M, Nicolle L, Borowy F, Borghi E, Recan D (1986) Metabolisme des monocarbones et trisomie 21: sensibilité au MTX. Ann Génét 29:16–19
Lewis DS (1981) Association between megakaryoblastic leukemia and Down's syndrome (Letter). Lancet II:695
Lewis DS, Thompson M, Hudson E, Liberman MM, Samson D (1983) Down's syndrome and acute megakaryoblastic leukemia: case report and review of the literature. Acta Haematol 70:236–242
Liu HP, Menaka H, Lin KH, Yong HS (1980) Congenital leukemoid reaction followed by fatal leukemia: a case with Down's syndrome. Am J Dis Child 134:939–941
Miller RW (1970) Neoplasia and down's syndrome. Ann NY Acad Sci 171:637–644
Morgan R, Hecht F, Cleary ML, Sklar J, Link MP (1985) Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 66:1466–1468
Nordan UZ, Humbert JR (1979) Myelofibrosis and acute lympho-blastic leukemia in a child with Down's syndrome. J Pediatr 94: 253–255
Patterson D, Graw S, Jones C (1981) Demonstration by somatic cell genetics of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21. Proc Natl Acad Sci (USA) 78:405–409
Peeters M, Jacubovicz D, Zipursky A (1985) Prescribed dosage of maintenance chemotherapy in acute lymphoblastic leukemia. Blood 64 [Suppl 1]:171 [Abstr 596]
Pui CH, Williams DL, Scarborough V, Jackson CW, Price R, Murphy S (1982) Acute megakaryoblastic leukemia associated with intrinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy. Br J Haematol 50:191–200
Robinson LL, Nesbit ME, Sather HN, Level C, Shahidi N, Kennedy A, Hammond D (1984) Down's syndrome and acute leukemia in children: a 10 year retrospective survey from the Children's Cancer Study Group. J Pediatr 105:235–242
Rogers PCJ, Thomas JW, Kalonsek DK, Baker MA, Denegri JF (1983) Neonate with Down's syndrome and transient congenital leukemia: in vitro studies. Am J Pediatr Hematol Oncol 5:59–64
Rowley JD (1981) Down's syndrome and acute leukemia: in creased risk may be due to trisomy 21. Lancet 2:1020–1022
Sariban E, Oliver C, Corash L, Cossman J, Whang-Peng J, Jaffe ES, Gralnick HR, Poplack DG (1984) Acute megakaryoblastic leukemia in childhood. Cancer 54:1423–1428
Seibel N, Sommer A, Miser J (1984) Transient neonatal leukemoid reactions in mosaic trisomy 21. J Pediatr 104:251–254
Sikand GS, Taysi K, Strandjord SE, Griffith R, Vietti TJ (1980) Trisomy 21 in bone marrow cells of a patient with prolonged preleukemic phase. Med Pediatr Oncol 8:237–242
Smith AG, Willoughby MLN (1982) Preleukemia in Down's syndrome (Letter). Blood 59:870
Suarez CR, LeBan MM, Silberman S, Fresco R, Rowley JD (1985) Acute megakaryoblastic leukemia in Down's syndrome: report of a case and review of cytogenetic findings. Med Pediatr Oncol 13:225–231
Ueda K, Kawaguchi Y, Kodama M, Tanaka Y, Usui T, Kamada N (1981) Primary myelofibrosis with myeloid metaplasia and cytogenetically abnormal clones in 2 children with Down's syndrome. Scand J Haematol 27:152–158
Weinberg AG, Schiller G, Windmiller J (1982) Neonatal leukemoid reaction: an isolated manifestation of mosaic trisomy 21. Am J Dis Child 136:310–311
Weinblatt ME, Higgins G, Ortega JA (1981) Aplastic anemia in Down's syndrome. Pediatrics 67:896–897
Weinstein HJ (1978) Congenital leukemia and the neonatal myeloproliferative syndrome associated with Down's syndrome. Clin Haematol 7:147–154
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peeters, M., Poon, A. Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr 146, 416–422 (1987). https://doi.org/10.1007/BF00444952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00444952